Clinical Trial Update: Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial compares stereotactic radiotherapy for oligometastatic disease across multiple tumor sites with palliative care; currently recruiting in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Disease

Snippet

Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia | Conditions: Oligometastatic Disease | Phase 2, Phase 3 | Status: RECRUITING